In this Issue:
Potent, naturally occurring saikosaponins inhibit HCV entry
Besifovir vs entecavir: similar viral suppression in HBV
Assessing tenofovir alafenamide in HBV
Disease-associated effects on hematopoiesis in HCV
SOF+Peg-IFN+RBV in treatment experienced GT2/3 HCV
The impact of HCV infection on host metabolism
HBV reactivation upon immunosuppression
Estimation of vertically-acquired HCV in Egypt
Hepatitis E vaccine looks promising
IL28B polymorphisms may contribute to HBsAg persistence
Please login below to download this issue (PDF)